Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 56, Status: Authorised

Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 56, Status: Authorised

Human medicines European public assessment report (EPAR): Fulvestrant Mylan, fulvestrant, Date of authorisation: 08/01/2018, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Fulvestrant Mylan, fulvestrant, Date of authorisation: 08/01/2018, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 13, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.